Abstract
Introduction
Diabetes Mellitus (DM) is a chronic disease caused by the inadequate production of insulin or ineffective usage of the provided insulin, marked by the increase in blood glucose (hyperglycemia), and found as an inherited disease. It is estimated that, there will be 300 million diabetic patients worldwide in 2025. 1 Diabetes has the potential to cause various complications due to angiopathy and neuropathy. It has long been studied about the relationship between DM and hearing loss. Disturbances in microcirculation and hemodynamic changes (including in cochlea) are often found in diabetic patients.
Further study on experimental animals such as diabetic rats has reported the pathological changes in outer hair cell, spiral ganglion and mitochondrial damage. 2 The similar result can also be found in a study conducted by Lee Several biochemical pathways have also been studied to discover the effect of hyperglycemia, such as diacylglycerol (DAG) activation pathway, protein kinase C (PKC) activation, increased polyol, increased oxidative stress and overproduction of advanced glycation end products (AGEP). These biochemical pathways are strongly related to the reactive oxygen species (ROS) leading to vascular damage. 4, 5 Some existing hypotheses explain the harmful side effects of hyperglycemia, one of them is the constant activation of PKC. PKC has been linked to vascular changes, such as increased permeability, contractility, extracellular matrix synthesis, cell growth and apoptosis, angiogenesis, cytokines activity and inhibition. 6 Curcumin is an active, yellow-colored component of turmeric, isolated from Curcuma longa plant. This molecule has a therapeutic effect on various diseases especially anti-inflammatory, anti-microbial, and antioxidant. It has been reported that curcumin is a bifunctional antioxidant possessing direct and indirect antioxidant activity by scavenging ROS and neutralizing them and inducting upregulation of various cytoprotective proteins and antioxidants such superoxide u n c o r r e c t e d p r o o f dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx). The presence of phenolic OH and CH2 groups in β-diketon part of this natural compound significantly contribute to its potent antioxidant property. 7, 8, 9 Curcumin affects the PKC and Ca 2+ regulation. The effect of inhibited ROS caused by curcumin depends on the curcumin dose through its effect on PKC activity and Ca 2+ regulation. 10 The role of curcumin in the treatment and prevention of hearing loss through its inhibitory mechanism towards PKC in cochlear fibroblasts of diabetic rat (Rattus novergicus) has never been studied, so the objective of this study is to demonstrate the role of curcumin in reducing the PKC expressions in the cochlear fibroblasts of diabetic rat (Rattus novergicus).
Materials and Methods

Animal Subjects
This study was an experimental study with randomized posttest-only control group design subjected to Wistar rats (Rattus norvegicus), male, healthy, average weight of 200 mg.
Twenty-four rats were divided into 6 groups, with 4 rats in each group. These 
Treatments
In the study, after the white rats adapted to the cage environment at the laboratory for two weeks, they were treated according to the plan. Group 1 (control group) was injected with single dose of sodium citrate, obtained from 1.47 gram sodium citrate solution in 50 mL dH2O intraperitoneally on the 1st day, and then terminated on the 5th day. Group 4 was injected with single dose of STZ 60 mg/kgbw followed by curcumin 400 mg/kgbw/day orally for 3 days and terminated on the 5th day.
Group 5 was injected with single dose of STZ 60 mg/kkgbw followed by curcumin 200 mg/kgbw/day orally for 8 days and terminated on the 10th day.
Group 6 was injected with single dose of STZ 60 mg/kgbw followed by curcumin 400 mg/kgbw/day orally for 8 days and terminated on the 10th day. 
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If the blood sugar is <200mg/dl then rats are eliminated from the sample.
After being diagnosed as hyperglycemic, the rats were given curcumin according to the required dose per group and rats were terminated after the procedure. To analyse the mean differences between more than two groups, OneWay ANOVA statistical test was used (a significance level of 0.05). Before One-Way ANOVA test, we did the Shapiro-Wilk test to proved that the data is normally distributed and Post Hoc Tests to see the defferences of groups.
Results
The mean differences of PKC expressions were seen in all groups. The lowest PKC expression was found in the control group and the highest PKC expression was found in diabetic group without curcumin administration (chart 1). The fibroblasts within diabetic group (group 2) showed higher density compared to other groups. Whereas the fibroblasts within the diabetic group with curcumin administration (group 3, 4, 5 and 6) showed lower density.
The obtained results from the histopathological examination above were then processed and analysed statistically to find the differences between each group and the interpreted results were shown in table 1.
According to table 1, there was a statistically significant difference (p<0.05) in the mean value of PKC expression between group 1 and diabetic group without curcumin administration (group 2).
As shown in table 1, it was found that the administration of curcumin for diabetic groups (group 3, 4, 5 and 6) decreased the PKC expressions significantly (p<0.05) compared to diabetic group without curcumin administration (group 2).
According to table 1, it was also found that the different doses (200 and 400mg/kgbw/day) and the duration of curcumin administration (3 and 8 days) showed no statistically significant differences (p>0.05) in PKC expressions.
u n c o r r e c t e d p r o o f
Discussion
Sensorineural hearing loss in diabetic patients is caused by cochlear angiopathy characterised by the dilatation of blood vessels of the stria vascularis, atrophy, and the loss of outer hair cells. A study on diabetic rats has found that microangiopathy occurs inside the inner ear and thickening of basement membranes of capillaries in stria vascularis. 14, 15 To help identifying the gene that play a role in human's auditory system, a rat is used as an experimental animal since it is genetically similar to a human (>70%). 16 The objective of this study is to learn the role of curcumin in decreasing the PKC expressions in the cochlear fibroblasts of diabetic rats
(Rattus novergicus).
The earlier studies have not proved the curcumin effect to the PKC expression in lateral wall of cochlear fibroblasts in diabetic model rats.This study is the first study which proved that curcumin is able to decreased the expression of PKC in lateral wall of cochlear fibroblasts in diabetic model rats.
The dose of curcumin used in this study was 200mg/kgbw according to the previous study, at which that mentioned dose of curcumin is able to act as an antioxidant 17 due to its inhibitory effect on ROS by affecting the PKC pathway and calcium regulation. 10 In order to find the optimal dose and duration of curcumin administration to decrease the PKC expressions, we compared the dose of 200 mg/kgbw/day and 400mg/kgbw/day with the duration of administration for 3 and 8 days. In regards to the existing study, curcumin is a compound that functionates dependently on the dose and duration of administration. Thus, the dose and duration of administration can affect the gene expression. 18 The significant difference in the mean value of PKC expression between control group and diabetic group without curcumin administration was found in this study. Curcumin as an antioxidant can inhibit ROS via PKC pathway and calcium regulation. 10 This discovery strengthens the presumption that hyperglycemia will cause cellular dysfunction that activates PKC persistently and stimulates the continuous synthesis of endogenous ROS, leading to cell damage, including cochlear fibroblasts.
u n c o r r e c t e d p r o o f
In this study, there were the differences in the mean values of PKC expression in all groups. The lowest PKC expression was found in the group 1 and the highest PKC expression was found in group 2.
Chronic hyperglycemia can cause various cellular reactions that play a role in the pathomechanism of various complications, caused by cell dysfunction and damage. The cellular reactions caused by chronic hyperglycemia are non-enzymatic glycation, the activation of signal transduction pathway increasing DAG synthesis, the increased ROS synthesis as the waste product of energy catabolism leaing to cell and tissue oxidative stress, and the activation of aldolase reductase. 19 In diabetes mellitus, the increased ROS production also occurs via a few mechanisms, such as polyol pathway, increased AGEs production, excessive radical superoxide production, and PKC activation. The increased PKC activity may also results in increased ROS production. 20 The increased DAG synthesis in hyperglycemia via signal transduction pathway, especially that comes from the transformation of glucose into glycerol 3-phosphate, may lead to an increased DAG synthesis de novo. DAG is partially synthesized from Phosphatidyl Choline and Phosphatidyl Inositol of "insulin-sensitive" cell membrane continuously. The perpetual DAG synthesis and the potentiation effect from the free fatty acid in the blood may initiate the PKC activation pathway persistently leading to cellular response, via the modification of various proteins controlling signal transduction and cytokine expression. 19, 21, 22 The modification of transcription factor and cell cycle may cause cell dysfunction and damage due to the disturbance in cell proliferation and differentiation as well as the abnormality in apoptosis. Additionally, the modification of transcription factor and post protein translation can also stimulate the synthesis of endogenous ROS resulting in cell damage. 19 Thereby, in STZ-induced diabetes group, PKC expression was increased due to the continuous activation of PKC pathway.
In this study, it was found that group 3, 4, 5 and 6 (diabetic group with curcumin administration) showed lower mean values of PKC expressions compared to group 2 (diabetic group without curcumin administration). The Fosforilase kinase is the key enzyme in glycogen metabolism, if this enzyme were inhibited then autocrine effect as cell growth factor also inhibited which affect the cell proliferation disturbance. other that, curcumin also a potent antioxidant to neutrelized ROS and inhibit the lipid peroxidation. 24 Similarly, the study carried out by Jancinova et al 25 has observed that curcumin can inhibit PKC in the neutrophils of Lewis rats suffering from arthritis in vitro or experimentally.
Another study has demonstrated that curcumin can serve as an antioxidant by eliminating phorbol-12, myristate-13 acetate (PMA) to inhibit ROS. This inhibitory pattern shows that curcumin mechanically inhibits PKC and calcium regulation. 10 The antioxidant activity of curcumin is based on the phenolic group in curcumin through donation of a hydrogen atom. Also, phenolic group plays a key role for the activity of free radicals scavenging. 26 In this study, the different doses of curcumin 200mg/kgbw/day and 400 mg/kgbw/day with the duration of 3 and 8 days showed no statistically significant differences (p>0.05) in PKC expressions. Nevertheless, the administration of higher dose of curcumin with longer duration (group 6) demonstrated more decreased PKC expression compared to lower dose of curcumin with shorter duration (group 3).
Conclusion
According to this study, we conclude that curcumin as an antioxidant This study can act as a basic science in traditional therapy to manage the hearing loss that caused by diabetes melitus in the future.
